Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Steven G. Gourlay ), FRACP, M.B.A., MBBS (M.D., Ph.D. | MD, CEO & Director | 602.18k | -- | 1960 |
| Mr. William Edward Souter BCom, IPAA, LLB (Adel) | Chief Financial Officer | 380.31k | -- | -- |
| Dr. Dana C. Hilt M.D. | Chief Medical Officer & Member of Depression and Cognition Clinical Advisory Board | 586.38k | -- | 1953 |
| Mr. Michael Roberts | Head of Investor Relations & Corporate Communications | -- | -- | -- |
| Prof. Paul Rolan D.C.P.S.A., F.F.P.M., F.R.A.C.P., M.B.B.S., M.D. | Head of Clinical Pharmacology & Lead Physician and Depression | 94.63k | -- | -- |
| Dr. Fujun Li Ph.D. | Head of Manufacturing | -- | -- | -- |
| Mr. Andrew B. Udell B.Sc., M.B.A. | Chief Commercial Officer | -- | -- | 1970 |
| Mr. Peter Gordon Webse B.Bus, FCIS, FCPA, FGIA, M.A.I.C.D. | Company Secretary | -- | -- | 1963 |
Actinogen Medical Limited
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It develops Xanamem, an oral medication and inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials, that achieves target engagement in the brain for the treatment of Alzheimer's disease, major depressive disorder, fragile x syndrome, and other neurological diseases. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.
Corporate Governance
Upcoming Events
February 24, 2025 at 4:28 AM UTC
Actinogen Medical Limited Earnings Date
Recent Events
Recent Events Information Not Available